Enzolytics Inc ENZC:OTCPK

RT Quote | Exchange | USD
Last | 02/03/23 EST
0.0428quote price arrow down-0.0006 (-1.3825%)
Volume
2,660,156
52 week range
0.02 - 0.10
Loading...
  • Open0.0433
  • Day High0.0435
  • Day Low0.0421
  • Prev Close0.0434
  • 52 Week High0.10
  • 52 Week High Date02/22/22
  • 52 Week Low0.02
  • 52 Week Low Date10/03/22

Key Stats

  • Market Cap121.143M
  • Shares Out2.83B
  • 10 Day Average Volume3.32M
  • Dividend-
  • Dividend Yield-
  • Beta-0.25
  • YTD % Change15.99

KEY STATS

  • Open0.0433
  • Day High0.0435
  • Day Low0.0421
  • Prev Close0.0434
  • 52 Week High0.10
  • 52 Week High Date02/22/22
  • 52 Week Low0.02
  • 52 Week Low Date10/03/22
  • Market Cap121.143M
  • Shares Out2.83B
  • 10 Day Average Volume3.32M
  • Dividend-
  • Dividend Yield-
  • Beta-0.25
  • YTD % Change15.99

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-87,789.997
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-19.07%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Enzolytics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused on developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically...
Address
120 W Pomona Ave
Monrovia, CA
91016
United States